MAG_HUMAN - dbPTM
MAG_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID MAG_HUMAN
UniProt AC P20916
Protein Name Myelin-associated glycoprotein
Gene Name MAG
Organism Homo sapiens (Human).
Sequence Length 626
Subcellular Localization Cell membrane
Single-pass type I membrane protein . Membrane raft .
Protein Description Adhesion molecule that mediates interactions between myelinating cells and neurons by binding to neuronal sialic acid-containing gangliosides and to the glycoproteins RTN4R and RTN4RL2 (By similarity). Not required for initial myelination, but seems to play a role in the maintenance of normal axon myelination. Protects motoneurons against apoptosis, also after injury; protection against apoptosis is probably mediated via interaction with neuronal RTN4R and RTN4RL2. Required to prevent degeneration of myelinated axons in adults; this probably depends on binding to gangliosides on the axon cell membrane (By similarity). Negative regulator of neurite outgrowth; in dorsal root ganglion neurons the inhibition is mediated primarily via binding to neuronal RTN4R or RTN4RL2 and to a lesser degree via binding to neuronal gangliosides. In cerebellar granule cells the inhibition is mediated primarily via binding to neuronal gangliosides. In sensory neurons, inhibition of neurite extension depends only partially on RTN4R, RTN4RL2 and gangliosides. Inhibits axon longitudinal growth (By similarity). Inhibits axon outgrowth by binding to RTN4R (By similarity). Preferentially binds to alpha-2,3-linked sialic acid. Binds ganglioside Gt1b (By similarity)..
Protein Sequence MIFLTALPLFWIMISASRGGHWGAWMPSSISAFEGTCVSIPCRFDFPDELRPAVVHGVWYFNSPYPKNYPPVVFKSRTQVVHESFQGRSRLLGDLGLRNCTLLLSNVSPELGGKYYFRGDLGGYNQYTFSEHSVLDIVNTPNIVVPPEVVAGTEVEVSCMVPDNCPELRPELSWLGHEGLGEPAVLGRLREDEGTWVQVSLLHFVPTREANGHRLGCQASFPNTTLQFEGYASMDVKYPPVIVEMNSSVEAIEGSHVSLLCGADSNPPPLLTWMRDGTVLREAVAESLLLELEEVTPAEDGVYACLAENAYGQDNRTVGLSVMYAPWKPTVNGTMVAVEGETVSILCSTQSNPDPILTIFKEKQILSTVIYESELQLELPAVSPEDDGEYWCVAENQYGQRATAFNLSVEFAPVLLLESHCAAARDTVQCLCVVKSNPEPSVAFELPSRNVTVNESEREFVYSERSGLVLTSILTLRGQAQAPPRVICTARNLYGAKSLELPFQGAHRLMWAKIGPVGAVVAFAILIAIVCYITQTRRKKNVTESPSFSAGDNPPVLFSSDFRISGAPEKYESERRLGSERRLLGLRGEPPELDLSYSHSDLGKRPTKDSYTLTEELAEYAEIRVK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
5Phosphorylation---MIFLTALPLFWI
---CCEECHHHHHHH
18.5225072903
15PhosphorylationPLFWIMISASRGGHW
HHHHHHHHCCCCCCC
11.6525072903
17PhosphorylationFWIMISASRGGHWGA
HHHHHHCCCCCCCCC
25.3525072903
29PhosphorylationWGAWMPSSISAFEGT
CCCCCCCCEEECCCE
18.0730631047
31PhosphorylationAWMPSSISAFEGTCV
CCCCCCEEECCCEEE
28.9330631047
36PhosphorylationSISAFEGTCVSIPCR
CEEECCCEEEECCCC
11.5330631047
99N-linked_GlycosylationLGDLGLRNCTLLLSN
HHHHCCCCCEEEEEC
28.337505568
99N-linked_GlycosylationLGDLGLRNCTLLLSN
HHHHCCCCCEEEEEC
28.337505568
101O-linked_GlycosylationDLGLRNCTLLLSNVS
HHCCCCCEEEEECCC
24.8028657654
106N-linked_GlycosylationNCTLLLSNVSPELGG
CCEEEEECCCHHHCC
37.957505568
106N-linked_GlycosylationNCTLLLSNVSPELGG
CCEEEEECCCHHHCC
37.957505568
223N-linked_GlycosylationGCQASFPNTTLQFEG
EEEEECCCCEEEEEE
43.627505568
223N-linked_GlycosylationGCQASFPNTTLQFEG
EEEEECCCCEEEEEE
43.627505568
246N-linked_GlycosylationPPVIVEMNSSVEAIE
CCEEEEECCCEEEEC
20.027505568
246N-linked_GlycosylationPPVIVEMNSSVEAIE
CCEEEEECCCEEEEC
20.027505568
315N-linked_GlycosylationENAYGQDNRTVGLSV
ECCCCCCCCEEEEEE
33.377505568
315N-linked_GlycosylationENAYGQDNRTVGLSV
ECCCCCCCCEEEEEE
33.377505568
406N-linked_GlycosylationGQRATAFNLSVEFAP
CCEEEEEEEEEECHH
29.017505568
406N-linked_GlycosylationGQRATAFNLSVEFAP
CCEEEEEEEEEECHH
29.017505568
430S-palmitoylationAARDTVQCLCVVKSN
HHCCEEEEEEEECCC
2.5029575903
432S-palmitoylationRDTVQCLCVVKSNPE
CCEEEEEEEECCCCC
4.3229575903
436PhosphorylationQCLCVVKSNPEPSVA
EEEEEECCCCCCCEE
46.11-
441PhosphorylationVKSNPEPSVAFELPS
ECCCCCCCEEEECCC
25.15-
450N-linked_GlycosylationAFELPSRNVTVNESE
EEECCCCCEECCHHH
37.847505568
450N-linked_GlycosylationAFELPSRNVTVNESE
EEECCCCCEECCHHH
37.847505568
454N-linked_GlycosylationPSRNVTVNESEREFV
CCCCEECCHHHHHEE
37.407505568
454N-linked_GlycosylationPSRNVTVNESEREFV
CCCCEECCHHHHHEE
37.407505568
531S-palmitoylationAILIAIVCYITQTRR
HHHHHHHHHHHHHCC
1.341703542
543PhosphorylationTRRKKNVTESPSFSA
HCCCCCCCCCCCCCC
39.8918510355
545PhosphorylationRKKNVTESPSFSAGD
CCCCCCCCCCCCCCC
19.2425332170
547PhosphorylationKNVTESPSFSAGDNP
CCCCCCCCCCCCCCC
40.9018510355
549PhosphorylationVTESPSFSAGDNPPV
CCCCCCCCCCCCCCE
35.3624076635
571PhosphorylationISGAPEKYESERRLG
ECCCCHHHHHHHHHC
24.03-
575MethylationPEKYESERRLGSERR
CHHHHHHHHHCCCHH
48.6954487783
620PhosphorylationLTEELAEYAEIRVK-
CHHHHHHHHHHEEC-
12.157525550

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of MAG_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of MAG_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of MAG_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
CO1A1_HUMANCOL1A1physical
2446864
CO2A1_HUMANCOL2A1physical
2446864
CO3A1_HUMANCOL3A1physical
2446864
CO4A1_HUMANCOL4A1physical
2446864
CO5A1_HUMANCOL5A1physical
2446864
CO6A1_HUMANCOL6A1physical
2446864
CO9A1_HUMANCOL9A1physical
2446864
FYN_HUMANFYNphysical
7525550
MAP1B_HUMANMAP1Bphysical
11733546
A4_HUMANAPPphysical
21832049

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of MAG_HUMAN

loading...

Related Literatures of Post-Translational Modification
N-linked Glycosylation
ReferencePubMed
"Identification of the glycosylated sequons of human myelin-associatedglycoprotein.";
Burger D., Pidoux L., Steck A.J.;
Biochem. Biophys. Res. Commun. 197:457-464(1993).
Cited for: GLYCOSYLATION AT ASN-99; ASN-106; ASN-223; ASN-246; ASN-315; ASN-406;ASN-450 AND ASN-454, AND LACK OF GLYCOSYLATION AT ASN-332.

TOP